MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Ireland
AbbVie Inc. (NYSE:ABBV)
Finance & Acquisition: AbbVie
Capstan Therapeutics
Organization & Developments: Capstan Therapeutics
Parents
Capstan Therapeutics
Children
*Capstan encodes mRNA and packages it in a lipid nanoparticle that is “decorated” with an antibody, which directs the body’s T-cells to attack problematic cells.
*Capstan’s foundation is built on research developed by world-renowned mRNA and cell therapy scientists and clinicians at the University of Pennsylvania
*Capstan’s modular platform leverages the biological and technological expertise of its founding scientists and includes proprietary targeted lipid nanoparticles (tLNP) technology, a suite of targeting moieties to mediate cell type-specific uptake, and disease-specific mRNA payloads aimed at directly engineering, or ablating pathogenic cells through in vivo generated CAR T cells
*Combining the power of cell therapy with the precision of genetic medicine
*Developing and delivering precise in vivo cell engineering to patients
*Therapy development focused on cell type-specific engineering across oncology, autoimmune disease, blood disorders, and fibrosis
2024: Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M
Jumps
Finance & Acquisitions: Capstan Therapeutics
Key People: Capstan Therapeutics